|
Match
|
Document |
Document Title |
|
|
6955873 |
Diagnosis and treatment system for reward deficiency syndrome (RDS) and related behaviors
The present invention relates to a kit and an intervenously administrable preparation, both, with a signal transmitter precursor, an enhancer of precursor uptake, and an inhibitor of...
|
|
|
6951890 |
Preventing and/or treating cardiovascular disease and/or associated heart failure
Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of...
|
|
|
6943193 |
Method for treating sexual dysfunction
Treatment of sexual dysfunction disorders comprising administering an effective amount of atomoxetine.
|
|
|
6943192 |
Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
Herein is disclosed a method of treating neoplastic disease, including cancer, comprising administering a pharmaceutical composition, the pharmaceutical composition comprising a highly concentrated...
|
|
|
6939876 |
Prevention of addiction in pain management
The present invention provides a composition for treating pain. The composition includes a pharmaceutically acceptable analgesic and a GABAergic agent, such as gamma vinyl GABA, effective in...
|
|
|
6939566 |
Microbicidal formulations and methods to control microorganisms
Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic...
|
|
|
6939893 |
Method of reducing toxicity of anticancer agents
The present invention discloses a method for enhancing the efficacy of anti-cancer agents. The method comprises administering to an individual, in need of such a treatment, an anti-cancer agent and...
|
|
|
6936636 |
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
Compounds of the formula:
where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side...
|
|
|
6936273 |
Liposomal analgesic formulation and use
A liposome formulation containing about 1% diclofenac is an effective topical anti-inflammatory topical treatment for lameness in horses. More particularly it has been discovered that a formulation...
|
|
|
6936637 |
Prevention of apoptosis in non-cancerous cells
Treatment of normal, non-cancerous, animal cells with an agent that depletes polyamines within the cells results in an inhibition of apoptosis when the cells are exposed to an inducer of apoptosis....
|
|
|
6932985 |
Azide method and composition for controlling deleterious organisms
Disclosed is both a method and composition for controlling deleterious organisms, such as insects, nematodes and weeds by applying a compound comprised of a liquid medium comprising azide and...
|
|
|
6908941 |
Hair and nail treatments using alkanolamines
Topical application of compositions containing an alkanolamine such as dimethylaminoethanol increase smoothness and surface uniformity of hair and nails and enhances hair and nail growth....
|
|
|
6905707 |
Controlled release arginine alpha ketoglutarate
An oral formulation of arginine α-ketoglutarate is disclosed which formulation is comprised of arginine α-ketoglutarate and one or more excipient materials. A wide range of different controlled...
|
|
|
6906051 |
Lactone integrin antagonists
The present invention relates to a class of compounds represented by the Formula I:
or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the...
|
|
|
6903136 |
Food supplements containing 4-hydroxyisoleucine and creatine
The present invention provides a dietary or food supplement for healthy humans that includes a combination of 4-hydroxyisoleucine and creatine, or nutraceutically acceptable derivatives of these...
|
|
|
6900180 |
Pharmaceutical compositions for alleviating discomfort
The invention relates to products for complete nutrition of infants or diseased or elderly persons. The products are characterized by increased levels of folic acid, vitamin B6 and vitamin B12 or...
|
|
|
6897238 |
Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris
Light treatments of sebaceous gland disorders with 5-aminolevulinic acid and photodynamic therapy are disclosed. A preferred treatment includes topical application of 5-aminolevulinic acid to the...
|
|
|
6887902 |
Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs
GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases.
|
|
|
6881424 |
Highly acidic metalated organic acid
A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a...
|
|
|
6867233 |
Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof
Acidic antimicrobial compositions for treating food surfaces and food contact surfaces comprise an organic acid and a surfactant, said composition having a pH of from about 2 to about 5....
|
|
|
6858624 |
Aryl fused azapolycyclic compounds
This invention is directed to compounds of the formula (I):
and their pharmaceutically acceptable salts, wherein R 1 , R 2 , and R 3 are as defined herein; intermediates for the synthesis of...
|
|
|
6855734 |
Glycine betaine and its use
Pharmaceutical uses of glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation, thrombi formation.
|
|
|
6852333 |
Agents and methods for promoting production gains in animals
The invention relates to compositions and methods for promoting production gains in animals, and of enhancing the efficacy of therapeutic agents. The gains are achieved through reduction in stress,...
|
|
|
6849711 |
Modifying tissue surfaces by liquid crystal formation
A method for modifying the surface properties of tissue in vivo is described The method comprises forming a liquid crystalline matrix on the tissue surface wherein the matrix comprises a tissue...
|
|
|
6849662 |
Therapeutic uses for nitric oxide inhibitors
The present invention is based on the discovery that nitric oxide (NO) is an important growth regulator in an intact developing organism. In particular, the present invention relates to a method of...
|
|
|
6844012 |
Use of selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing said treatment
The invention concerns the use of at least a molecule containing selenium, in an amount corresponding to a daily dose of about 2 to 40 mg, even 80 mg of atomic selenium equivalent, on its own or...
|
|
|
6844320 |
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both,...
|
|
|
6841173 |
Compositions and methods directed towards sore muscles and joints
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
|
|
|
6838095 |
Ionic silver complex
The invention relates to a substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic,...
|
|
|
6835751 |
Bicyclic amino acids as pharmaceutical agents
The compounds of the instant invention are bicyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression,...
|
|
|
6835398 |
Method of administering high-dose, oral magnesium for treatment of chronic pain syndrome of erythromelalgia
A method of treating patients, particularly for pain and/or symptoms of erythromelalgia, and other neurovascular or neuropathic disorders, etc. involves administering high doses of magnesium. The...
|
|
|
6833140 |
Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
The present invention provides an extended release oral dosage form of prodrugs of gabapentin and other GABA analogs, which dosage forms exhibit reduced toxicity. The dosage forms are particularly...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6830692 |
Amino acid composition for hemodialysis
The invention relates to a special amino acid mixture for hemodialysis as well as to the dialysis solution that can be prepared from the amino acid mixture. When the amino acid mixtures according...
|
|
|
6827930 |
System for attracting fish
A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or...
|
|
|
6822002 |
Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
The use of L-carnitine and its alkanoyl devivatives, optionally in the form of a pharmaceutically acceptable salt, as osmotic agents in the preparation of solutions for medical use, particularly...
|
|
|
6812249 |
Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
This invention relates to a process for synthesis and method of use of an effective amount of a 3-hydroxy-3-methylbutyrate (HMB) amino acid salt for the regulation athletic function in humans.
|
|
|
6806261 |
Methods for treating certain diseases using naaladase inhibitors
The present invention relates to methods for regulating the release of TGF-β from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a...
|
|
|
6803367 |
Substance for inducing apoptosis
A substance for inducing apoptosis represented by specific formulae. A pharmaceutical composition which can be used for an anticancer agent containing said substance.
|
|
|
6803060 |
Composition to boost libido
There is provided a natural composition for boosting the libido of an individual, the composition including an effective amount of an aphrodisiac and a compound to increase blood flow to the pelvic...
|
|
|
RE38604 |
Fluid therapy with L-lactate and/or pyruvate anions
Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and...
|
|
|
6794414 |
Method and compositions for treating diseases mediated by transglutaminase activity
Diseases Mediated by transglutaminase, such as Huntington's Disease, spinobulbar atrophy, spinocerebellar ataxia, and dentatorubralpallidoluysian atrophy, as well as inflammatory diseases of the...
|
|
|
6784208 |
Method for preventing and treating visceral pain and gastrointestinal disorders
The compounds of formula I-IV: wherein n is an integer of from 1 to 4, or pharmaceutically acceptable salts thereof are useful to prevent and treat visceral pain and gastrointestinal disorders.
|
|
|
6770676 |
Dicarboxylic acid derivatives
The present invention relates to 2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives represented by the formula: the pharmaceutically acceptable salts thereof, or the hydrates...
|
|
|
6759061 |
Liver function improvement formulation
A food supplement formulation effective to improve the function of the liver comprises selenium, milk thistle seed, phosphatidyl choline, dandelion root, l-methionine, l-taurine, N-acetyl-cysteine,...
|
|
|
6746678 |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
This invention defines a novel method for treatment of several neurological diseases and pathophysiologically related symptomology, said diseases including peripheral neuropathies, secondary...
|
|
|
6743433 |
Treatment of acne using alkanolamine compositions
Acne is treated or prevented by the topical application of compositions containing an alkanolamine such as dimethylaminoethanol, tyrosine, and a sulfur ingredient such as lipoic acid or...
|
|
|
6733793 |
Oral composition with insulin-like activities and methods of use
An orally administered, novel dietary supplement or therapeutic composition capable of insulin-like activity in animals, preferably humans, is provided. Contained in the composition are...
|
|
|
6730693 |
Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
Double fumarates of L-carnitine or isovaleryl L-carnitine and an amino acid having formula (I) are disclosed which are useful as active ingredients of food supplements, dietary supplements or...
|
|
|
6720356 |
Magnesium di-potassium EDTA complex and method of administration
A composition containing an EDTA complex in the form of a suppository is provided. More specifically, the EDTA complex is a magnesium di-potassium EDTA complex. The suppository may contain a...
|